PDF) P769 In Crohn's disease, an aggressive disease course is related to an increased abundancy of proteobacteria: a seven year follow up study
Y-ECCO (@Y_ECCO_IBD) / Twitter
Ustekinumab persistence high, safe at 12 months in 'difficult-to-treat' Crohn's patients
Medflixs - The 15th Congress of European Crohn's and Colitis Organisation, ECCO 2020
Medflixs - The 16th Congress of European Crohn's and Colitis Organisation, ECCO 2021
ECCO Conference Center - ECCO
European Cancer Congress 2013 (ECCO-ESMO-ESTRO)
Y-ECCO (@Y_ECCO_IBD) / Twitter
European Crohn´s and Colitis Organisation - ECCO - Past Congresses
Y-ECCO (@Y_ECCO_IBD) / Twitter
Y-ECCO (@Y_ECCO_IBD) / Twitter
European Crohn´s and Colitis Organisation - ECCO - Home
Resources - ECCO
PDF) P599 Home testing for faecal calprotectin: follow-up results from the first UK trial
European Crohn´s and Colitis Organisation - ECCO - 12th Congress of ECCO, Barcelona 2017
Change of management in ECCO Sko A/S - ECCO Group
15th Congress of ECCO IBD beyond 2020 Jan 25: Format. Button? - ppt download
ECCO EFCCA Patient Guidelines | EFCCA
Medflixs - The 15th Congress of European Crohn's and Colitis Organisation, ECCO 2020
Y-ECCO (@Y_ECCO_IBD) / Twitter
Y-ECCO (@Y_ECCO_IBD) / Twitter
European Crohn´s and Colitis Organisation - ECCO - Home
ECCO Congress | EFCCA
ECCO IBD on the App Store
European Crohn´s and Colitis Organisation - ECCO - Past Congresses
